June 15, 2024

Biopsy Devices Market Size To Attain USD 4.29 Billion By 2032

The biopsy devices market size was estimated at US$ 2.29 billion in 2023 it is predicted to grow at a CAGR of 7.20% from 2023 to 2032 to reach around US$ 4.29 billion by 2032.

Biopsy Devices Market Size 2023 To 2032

Key Takeaways

  • North America region contributed more than 34% of revenue share in 2022.
  • Asia-Pacific is estimated to expand the fastest CAGR between 2023 and 2032.
  • By product, the needle-based biopsy guns segment held the largest market share of 36% in 2022.
  • By product, the biopsy needles segment is anticipated to grow at a remarkable CAGR of 8.6% between 2023 and 2032.
  • By end use, the hospitals segment generated over 46% of revenue share in 2022.
  • By end use, the clinics segment is expected to expand at the fastest CAGR over the projected period

The biopsy devices market report offers an exclusive study of the present state expected at the market dynamics, opportunities, market scheme, growth analysis and regional outlook. The report presents energetic visions to conclude and study the market size, market aspiration, and competitive environment. The research also focuses on the important achievements of the market, research & development, and regional (country by country) growth of the leading vendors operating in the market

The study offers intricate dynamics about different aspects of the global biopsy devices market, which aids companies operating in the market in making strategies development decisions. The study also elaborates on remarkable changes that are highly anticipated to configure growth of the global biopsy devices market during the forecast period. It also includes a key indicator analysis that highlights growth prospects of this market and approximate statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/3612

Biopsy Devices Market Scope

Report CoverageDetails
Growth Rate from 2023 to 2032CAGR of 7.20%
Market Size in 2023USD 2.29 Billion
Market Size by 2032USD 4.29 Billion
Largest MarketNorth America
Base Year2022
Forecast Period2023 to 2032
Segments CoveredBy Application and By End Use
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

This study covers an elaborate segmentation of the global biopsy devices market, along with important information and a competition outlook. The report mentions company profiles of players that are currently influence the global biopsy devices market, wherein various developments, expansions, and winning strategies practiced and execute by leading players have been presented in detail.

Read Also: X-Ray Detectors Market Size To Attain USD 5.81 Billion By 2032

Biopsy Devices Market Players

  • Medtronic plc
  • Becton, Dickinson, and Company
  • Hologic, Inc.
  • Boston Scientific Corporation
  • Olympus Corporation
  • C. R. Bard, Inc. (acquired by BD)
  • Cook Medical LLC
  • FUJIFILM Holdings Corporation
  • Mauna Kea Technologies
  • Devicor Medical Products, Inc.
  • Leica Biosystems Nussloch GmbH (Danaher Corporation)
  • INRAD Inc.
  • Argon Medical Devices, Inc. (acquired by Shandong Weigao Group Medical Polymer Company Limited)
  • Scion Medical Technologies LLC
  • MDxHealth SA

Segments Covered in the Report

By Application

  • Needle-based Biopsy Guns
  • Biopsy Guidance Systems
  • Biopsy Forceps
  • Biopsy Needles

By End Use

  • Hospitals
  • Clinics
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Research Methodology

The research methodology acquire by analysts for assemble the global biopsy devices market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts study numerous annual report declaration, white papers, market association declaration, and company websites to obtain the necessary understanding of the global biopsy devices market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Biopsy Devices Market 

5.1. COVID-19 Landscape: Biopsy Devices Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Biopsy Devices Market, By Application

8.1. Biopsy Devices Market Revenue and Volume, by Application, 2023-2032

8.1.1. Needle-based Biopsy Guns

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. Biopsy Guidance Systems

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

8.1.3. Biopsy Forceps

8.1.3.1. Market Revenue and Volume Forecast (2020-2032)

8.1.4. Biopsy Needles

8.1.4.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global Biopsy Devices Market, By End Use

9.1. Biopsy Devices Market Revenue and Volume, by End Use, 2023-2032

9.1.1. Hospitals

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Clinics

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

9.1.3. Others

9.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global Biopsy Devices Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.1.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.1.3. U.S.

10.1.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.1.3.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.1.4.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.2. Europe

10.2.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.2.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.2.3. UK

10.2.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.2.3.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.2.4. Germany

10.2.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.2.4.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.2.5. France

10.2.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.2.5.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.2.6.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.3. APAC

10.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.3.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.3.3. India

10.3.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.3.3.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.3.4. China

10.3.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.3.4.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.3.5. Japan

10.3.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.3.5.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.3.6.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.4. MEA

10.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.4.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.4.3. GCC

10.4.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.4.3.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.4.4. North Africa

10.4.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.4.4.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.4.5. South Africa

10.4.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.4.5.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.4.6.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.5. Latin America

10.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.5.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.5.3. Brazil

10.5.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.5.3.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.5.4.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

Chapter 11. Company Profiles

11.1. Medtronic plc

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Becton, Dickinson, and Company

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Hologic, Inc.

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Boston Scientific Corporation

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Olympus Corporation

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. C. R. Bard, Inc. (acquired by BD)

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Cook Medical LLC

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. FUJIFILM Holdings Corporation

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Mauna Kea Technologies

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Devicor Medical Products, Inc.

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com